PointState Capital LP
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1509842
New York, NY
Position in TEVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$59,450,313
-$58,959,990 QoQ
Shares Held
1,973,782
-48.0% QoQ
Ownership
0.170%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Dec 31, 2025CallValue
$114,606,241
CallShares
3,672,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PointState Capital LP holds $59,450,313 across 1 Drug Manufacturers - Specialty & Generic name. TEVA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
1,973,782 | $59,450,313 |
All Filings in TEVA
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,450,313 | 1,973,782 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $118,410,303 | 3,793,986 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $114,606,241 | 3,672,100 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $418,390,439 | 20,712,398 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $74,176,420 | 3,672,100 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $347,139,790 | 20,712,398 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $61,544,396 | 3,672,100 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $56,440,177 | 3,672,100 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $232,570,970 | 15,131,488 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $55,100,000 | 2,500,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $298,123,509 | 13,526,475 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $45,050,000 | 2,500,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $175,845,358 | 9,758,344 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $148,634,248 | 9,146,723 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $40,625,000 | 2,500,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $72,031,112 | 5,104,969 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||